Pharmaceutical composition for treating thalassemia, comprises folic acid, vitamin E, L- arginine, calcium carbonate, zinc, magnesium and N-acetylcysteine, alpha lipoic acid, Tocotrienols, Vitamin C, Vitamin D3, Vitamin A, Vitamin B12, Zinc, selenium, and calcium citrate maleate
2024-07-29
专利权人AGRAWAL S (AGRA-Individual)
申请日期2024-07-29
专利号IN202411057248-A
成果简介NOVELTY - Pharmaceutical composition comprises: 0.025-0.065 wt.% folic acid, 0.55-0.95 wt.% vitamin E, 15.5-35.5 wt.% L- arginine, 8.3-16.3 wt.% calcium carbonate, 0.1-2.1 wt.% zinc, 8.3-16.3 wt.% magnesium and 39.05-59.05 wt.% N-acetylcysteine, 140-160 mg alpha lipoic acid, 40-60 mg Tocotrienols, 30-500 mg Vitamin C, 150-220 I.U. Vitamin D3, 1000 I.U. Vitamin A, 2.0-2.50 Mcg Vitamin B12, 9-12 mg Zinc, 40-60 mcg selenium, and 200-300 mg calcium citrate maleate. USE - Pharmaceutical composition for treating thalassemia. No biological data given. ADVANTAGE - The composition is safe, easy to administer, stable, efficient, economic, and reduces overall oxidative stress in the body.
IPC 分类号A61K-031/07 ; A61K-031/155 ; A61K-031/355 ; A61K-031/375 ; A61K-031/519 ; A61K-031/593 ; A61K-009/00 ; A61P-007/06
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/15637
专题中国科学院新疆生态与地理研究所
作者单位
AGRAWAL S (AGRA-Individual)
推荐引用方式
GB/T 7714
AGRAWAL S. Pharmaceutical composition for treating thalassemia, comprises folic acid, vitamin E, L- arginine, calcium carbonate, zinc, magnesium and N-acetylcysteine, alpha lipoic acid, Tocotrienols, Vitamin C, Vitamin D3, Vitamin A, Vitamin B12, Zinc, selenium, and calcium citrate maleate. IN202411057248-A[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。